Uric acid levels in sera from patients with multiple sclerosis. 2001

J Drulović, and I Dujmović, and N Stojsavljević, and S Mesaros, and S Andjelković, and D Miljković, and V Perić, and G Dragutinović, and J Marinković, and Z Lević, and M Mostarica Stojković
Institute of Neurology, Clinical Centre of Serbia, School of Medicine, University of Belgrade, Dr Subotića 6, Belgrade 11000, Yugoslavia. chcondru@EUnet.yu

The levels of uric acid (UA), a natural peroxynitrite scavenger, were measured in sera from 240 patients with multiple sclerosis (MS) and 104 sex- and age-matched control patients with other neurological diseases (OND). The mean serum UA concentration was lower in the MS than in the OND group, but the difference did not reach the level of statistical significance (P = 0.068). However, the mean serum UA level from patients with active MS (202.6 + 67.1 mumol/l) was significantly lower than that in inactive MS patients (226.5 + 78.6 mumol/l; P = 0.046) and OND controls (P = 0.007). We found a significant inverse correlation of serum UA concentration with female gender (P = 0.0001), disease activity (P = 0.012) and duration (P = 0.017), and a trend towards an inverse correlation with disability as assessed by EDSS score, which did not reach statistical significance (P = 0.067). Finally, multivariate linear regression analyses showed that UA concentration was independently correlated with gender (P = 0.0001), disease activity (P = 0.014) and duration of the disease (P = 0.043) in MS patients. These findings suggest that serum UA might serve as a possible marker of disease activity in MS. They also provide support to the potential beneficial therapeutic effect of radical-scavenging substances in MS.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D004185 Disability Evaluation Determination of the degree of a physical, mental, or emotional handicap. The diagnosis is applied to legal qualification for benefits and income under disability insurance and to eligibility for Social Security and workmen's compensation benefits. Disability Evaluations,Evaluation, Disability,Evaluations, Disability
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

J Drulović, and I Dujmović, and N Stojsavljević, and S Mesaros, and S Andjelković, and D Miljković, and V Perić, and G Dragutinović, and J Marinković, and Z Lević, and M Mostarica Stojković
April 2011, Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology,
J Drulović, and I Dujmović, and N Stojsavljević, and S Mesaros, and S Andjelković, and D Miljković, and V Perić, and G Dragutinović, and J Marinković, and Z Lević, and M Mostarica Stojković
January 2009, Clinical chemistry and laboratory medicine,
J Drulović, and I Dujmović, and N Stojsavljević, and S Mesaros, and S Andjelković, and D Miljković, and V Perić, and G Dragutinović, and J Marinković, and Z Lević, and M Mostarica Stojković
March 2012, Neurological research,
J Drulović, and I Dujmović, and N Stojsavljević, and S Mesaros, and S Andjelković, and D Miljković, and V Perić, and G Dragutinović, and J Marinković, and Z Lević, and M Mostarica Stojković
June 2008, Clinical neurology and neurosurgery,
J Drulović, and I Dujmović, and N Stojsavljević, and S Mesaros, and S Andjelković, and D Miljković, and V Perić, and G Dragutinović, and J Marinković, and Z Lević, and M Mostarica Stojković
June 2001, Multiple sclerosis (Houndmills, Basingstoke, England),
J Drulović, and I Dujmović, and N Stojsavljević, and S Mesaros, and S Andjelković, and D Miljković, and V Perić, and G Dragutinović, and J Marinković, and Z Lević, and M Mostarica Stojković
March 2008, Multiple sclerosis (Houndmills, Basingstoke, England),
J Drulović, and I Dujmović, and N Stojsavljević, and S Mesaros, and S Andjelković, and D Miljković, and V Perić, and G Dragutinović, and J Marinković, and Z Lević, and M Mostarica Stojković
April 2006, Neurological research,
J Drulović, and I Dujmović, and N Stojsavljević, and S Mesaros, and S Andjelković, and D Miljković, and V Perić, and G Dragutinović, and J Marinković, and Z Lević, and M Mostarica Stojković
September 2004, Therapeutische Umschau. Revue therapeutique,
J Drulović, and I Dujmović, and N Stojsavljević, and S Mesaros, and S Andjelković, and D Miljković, and V Perić, and G Dragutinović, and J Marinković, and Z Lević, and M Mostarica Stojković
January 2021, Bratislavske lekarske listy,
J Drulović, and I Dujmović, and N Stojsavljević, and S Mesaros, and S Andjelković, and D Miljković, and V Perić, and G Dragutinović, and J Marinković, and Z Lević, and M Mostarica Stojković
May 2013, Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia,
Copied contents to your clipboard!